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DNA methylation is a heritable modification of genomic DNA central to development, imprinting, transcriptional reg-
ulation, chromatin structure, and overall genomic stability. Aberrant DNA methylation of individual genes is a hallmark
of cancer and has been shown to play an important role in neurological disorders such as Rett syndrome. Here, we asked
whether normal DNA methylation might distinguish individual brain regions. We determined the quantitative DNA
methylation levels of 1,505 CpG sites representing 807 genes with diverse functions, including proliferation and differ-
entiation, previously shown to be implicated in human cancer. We initially analyzed 76 brain samples representing
cerebral cortex ( ), cerebellum ( ), and pons ( ), along with liver samples ( ) from 43 individuals.np 35 np 34 np 7 np 3
Unsupervised hierarchical analysis showed clustering of 33 of 35 cerebra distinct from the clustering of 33 of 34 cerebella,
7 of 7 pons, and all 3 livers. By use of comparative marker selection and permutation testing, 156 loci representing 118
genes showed statistically significant differences—a17% absolute change in DNA methylation ( )—among brainP ! .004
regions. These results were validated for all six genes tested in a replicate set of 57 samples. Our data suggest that DNA
methylation signatures distinguish brain regions and may help account for region-specific functional specialization.
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Epigenetics—the study of information heritable during
cell division, other than the DNA sequence itself—might
help to explain the mechanism by which one tissue is
distinguished from another developmentally.1 Although
cells of varying lineage in a single individual share the
same DNA sequence, they remember their tissue of origin
when they divide. DNA methylation is an epigenetic mark
involving a covalent modification of the nucleotide cy-
tosine that occurs in vertebrates at CpG dinucleotides
and is generally associated with gene silencing, with no-
table exceptions, such as some regulatory elements con-
trolling genomic imprinting.2 Disruption of DNA meth-
ylation is a hallmark of cancer, with genomewide and
gene-specific hypomethylation and hypermethylation of
genes and genomic regions.3 DNA methylation is also
likely to be important in normal brain development. Rett
syndrome (MIM 312750), which involves loss of the nor-
mal MeCP2 methylcytosine-recognition protein, causes
loss of neurodevelopmental milestones, severe mental re-
tardation, and motor dysfunction.4 Most studies of DNA
methylation in normal and disease-affected tissues have
been focused on individual genes. However, recent tech-
nology allows high-throughput methylation analysis of
larger numbers of CpG sites (from hundreds to thou-
sands) across the genome.5
The human brain is a complex organ, and, although a
great deal is now known about variations in gene expres-
sion that distinguish brain regions, an epigenetic connec-
tion to brain anatomy has not been explored. Several stud-
ies have examined brain region–specific large-scale gene-
expression variation in the mouse. Sandberg et al. found
that gene expression in the cerebellum was most distinct
when its profile was compared with that of the cerebral
cortex, the midbrain, and the hippocampus, with 23 genes
expressed uniquely in cerebellum and 28 genes absent
there, although expressed in other regions.6 A second
study found 1,489–3,220 genes (depending on the thresh-
old used) differentially expressed across five brain re-
gions.7 Finally, a third large-scale study of mouse brain
gene expression, The Allen Brain Atlas project, identified
region-specific gene expression across 12 brain regions.8
Similarly, microarray studies in human postmortem brain
samples have revealed substantial gene-expression differ-
ences among the caudate nucleus, cerebellum, and cere-
bral cortex, as well as differences of smaller magnitude
among cerebral cortex regions, including Broca’s area, pre-
frontal cortex, premotor cortex, primary visual cortex, and
anterior cingulate cortex.9 More recently, Roth and col-
leagues10 profiled 65 distinct human tissues, including 20
CNS tissues. They demonstrated a robust distinction be-
tween CNS tissues as a whole and various non-CNS tissues.
Furthermore, within the CNS tissues, they discovered re-
gion-specific transcriptional expression and a strikingly
distinct cerebellar profile, as compared with all other CNS
tissues.10 Although much research has elucidated brain re-
gion–specific gene-expression differences, no comprehen-
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Table 1. Characteristics of 43 Individuals from
Whom 76 Brain Samples Were Analyzed
Characteristic
CBLa
( )np 34
CMb
( )np 35
PNc
( )np 7
Aged (years) 20.613.6 28.622.1 64.424.3
Sex:
Female 6 7 1
Male 27 27 6
Indeterminate 1 1 0
PMId,e (h) 19.212.4 18.710.6 20.57.4
Race:
White 11 13 0
African American 12 12 0
Unknown 11 10 7
Cause of death:
Accident 8 5 0
Asphyxia 1 1 0
Cardiopulmonary 6 7 1
Drowning 6 7 0
Epiglottitis 1 1 0
Pancreatitis 1 1 0
Pneumonia 0 1 1
Thermal burns 0 1 0
Seizures 1 1 0
Suicide 1 1 0
Unknown 9 9 5
Diagnosis:
Normal 18 16 3
Autism 16 15 0
Bipolar 0 4 4
a CBL p cerebellum.
b CM p cerebrum.
c PN p pons.
d Values are given as meanSD.
e PMI p postmortem interval (time from death to tissue
freezing).
sive survey of methylation in rodent or human brain has
yet been attempted.
The recent application of high-throughput technology
to the field of epigenetics enables researchers to perform
large-scale studies of DNA methylation at thousands of
CpG dinucleotides across hundreds of genes. Here, we
measured methylation levels at 1,505 CpG sites repre-
senting 807 genes, using the Illumina GoldenGate Meth-
ylation Cancer Panel I platform,11 to determine whether
methylation profiles vary in brain tissues.
Snap-frozen tissues were acquired from the Harvard
Brain Tissue Resource Center at McLean Hospital, Bel-
mont, MA, and from the National Institute of Child
Health and Human Development (NICHD) Brain and Tis-
sue Bank for Developmental Disorders at the University
of Maryland, Baltimore. A summary of characteristics for
the 76 brain samples representing 43 individuals analyzed
in our study can be found in table 1. Care was taken to
dissect tissue away from white matter and blood vessels.
Genomic DNA was isolated for all samples included in the
study by use of the MasterPure DNA purification kit (Ep-
icentre Biotechnologies) in accordance with the manu-
facturer’s specifications. Bisulfite conversion of 500 ng of
genomic DNA was achieved through use of the EZ DNA
methylation gold kit (Zymo Research). Bisulfite treatment
of genomic DNA results in unmethylated cytosine nucle-
otides being changed to thymidine while methylated cy-
tosines remain unchanged. This difference is then de-
tected as a C/T nucleotide polymorphism at each CpG site.
A total of 83 samples (76 brain samples with matched
specimens) were run on the Illumina platform, and a b
value of 0–1.0 was reported for each CpG site, signifying
the percentage of methylation. b values were calculated
by subtracting background with use of negative controls
on the array and taking the ratio of the methylated signal
intensity to the sum of both methylated and unmethy-
lated signals.11 The Illumina GoldenGate methylation as-
say is reported to be accurate for b value differences0.17,
which was thus chosen as our threshold for methylation
differences. Sample quality was assessed by computing
mean methylation levels across all samples (0.33), ex-
cluding two outliers (four samples with means of 0.22 and
0.40). Array quality was also assessed through linear re-
gression of the correlation of two pairs of replicate samples
showing values of 0.991 and 0.982. Computational anal-2r
ysis was performed using the GenePattern12 comparative
marker–selection module, to define specific loci with the
greatest difference in methylation levels between tissues.
In defining our list of significantly different loci, we ap-
plied two constraints: (1) , as determined by com-P ! .004
parative marker–selection analysis (with use of a two-sided
t test statistic), and (2) mean methylation-level difference
across brain regions 0.17.
In the first experiment, we examined 8 cerebral cortex
samples and 16 cerebellar samples from 24 individuals,
analyzing 1,532 loci representing 473 genes from two
sources. The first was a group of 380 CpG sites, including
those normally found in methylated CpG islands and in
GC-rich sequences and those with methylation changes
in response to trichostasin A (TSA) or 5-aza-deoxycytidine
treatment that we had identified earlier through a system-
atic genomewide screen.13,14 The second was a group of
1,152 loci from the Illumina Golden Gate Methylation
Cancer Panel I.11 The Illumina panel was employed be-
cause it has already been validated on human tissue sam-
ples, including colon, lung, ovary, breast, and prostate,
and the set of genes included in the panel are growth-
and development-related and thus might also influence
brain development.11 Hierarchical clustering analysis re-
vealed a striking separation of gene methylation between
specimens from the two brain regions, with clustering of
7 of 8 cerebral cortex samples and 15 of 16 cerebellar
samples (fig. 1). The greatest number of methylation dif-
ferences was related to brain region rather than to age,
sex, postmortem interval, race, diagnosis, or cause of
death (fig. 2). Please note that, in the subsequent exper-
iments described below, comparisons were made in the
same individual, thereby negating differences due to these
other factors. The top 20 differentially methylated probes,
with and a minimum mean methylation changeP ! .004
of 17% across the two tissues, are provided in table 2.
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Figure 1. Hierarchical clustering of methylation data from ce-
rebral cortex and cerebellum samples analyzed in experiment 1.
Methylation profiles of 1,532 CpG sites from 24 brain samples (16
cerebella and 8 cerebra) from 24 individuals were clustered using
uncentered correlation and pairwise average linkage. Columns rep-
resent samples; rows correspond to CpG sites. Two major branches
are defined by our methylation data and correlate with brain re-
gion, one containing 7 of 8 cerebra and one containing 15 of 16
cerebella. A heat map showing relative methylation differences
(red indicates more methylated; blue indicates less methylated)
from a handful of analyzed loci is represented in the clustering
dendrogram.
Figure 2. Hierarchical clustering of methylation data from ce-
rebral cortex and cerebellum samples analyzed in experiment 1.
Methylation profiles of 1,532 CpG sites from 24 brain samples (16
cerebella and 8 cerebra) from different individuals were clustered
using uncentered correlation and pairwise average linkage. Col-
umns represent samples; rows are color bars that correspond to
sample characteristics. As shown by the color bars, the two major
dendrogram branches defined by our methylation data correlate
most strongly with brain region, as opposed to age, sex, post-
mortem interval (PMI), cause of death (COD), or race.
Genes showing significant relative hypomethylation in
the cerebral cortex compared with the cerebellum in-
cluded engrailed 2 (EN2 [MIM 131310]) (table 2), which
influences cerebellar development15 and may play a role
in autism (MIM 209850),16 and HDAC7A (MIM 606542),
which encodes part of a family of enzymes that regulate
chromatin remodeling in the brain. Among those hypo-
methylated in cerebellum was HTR2A (MIM 182135),
which is epigenetically regulated17 and encodes a seroto-
nin receptor implicated in many neuropsychiatric phe-
notypes.18 One limitation of this experiment is that the
samples were not paired from the same individual and
thus could represent interindividual variation.
In the second experiment, we tested the potential con-
founding effect of interindividual variation by examining
tissues from 26 individuals, including additional brain
regions of 14 individuals from experiment 1, thus provid-
ing perfectly matched cerebral cortex and cerebellum, as
well as matched liver from three individuals. In this ex-
periment, we examined 1,505 CpGs from 807 genes on
the Illumina Golden Gate Methylation Cancer Panel I.11
This set of genes included 621 loci also represented on the
array in experiment 1. In the second experiment, there
was just as dramatic a separation of gene methylation as
that seen in the first experiment, with clustering of 25 of
26 cerebral cortex samples, 26 of 26 cerebellar samples,
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Table 2. Loci Demonstrating Significant Differential Methylation
( ; ) between Cerebellum and Cerebral Cortex fromP ! .004 b 1 0.17
Unmatched Individuals
Feature IDa
Cerebellum
Cerebral
Cortex
Differenceb P
False-
Discovery
RateMeanb SD Meanb SD
SFTPA1_E340_R .16 .15 .73 .36 .57 .002 .02
RBP1_P426_R .80 .08 .31 .29 .48 .002 .02
TIMP2_S1512_Fc .58 .12 .18 .21 .41 .002 .02
EN2_B_S1503_Fc .52 .15 .16 .24 .35 .002 .02
PRSS8_E134_R .37 .09 .72 .22 .35 .002 .02
HTR2A_P1387_R .27 .07 .60 .20 .33 .002 .02
HDAC7A_P344_F .75 .03 .43 .24 .33 .002 .02
IL16_P93_R .79 .07 .46 .23 .32 .002 .02
CDH3_P779_Fc .15 .05 .46 .25 .31 .002 .02
PDGFRB_P273_F .50 .22 .20 .20 .30 .004 .03
ZP3_P220_F .24 .09 .53 .21 .30 .002 .02
SLC5A5_E60_F .78 .15 .50 .23 .28 .002 .02
ASB4_P391_F .40 .05 .68 .18 .28 .002 .02
GSTM2_P453_R .76 .13 .48 .22 .27 .002 .02
KCNK4_P257_Fc .22 .08 .49 .19 .27 .002 .02
BLK_E202_Fc .08 .05 .35 .22 .27 .002 .02
PTPN6_P126_Rc .04 .02 .31 .18 .26 .002 .02
APOA1_P261_F .84 .04 .58 .21 .25 .002 .02
HLA_DPB1_S746_Fc .17 .13 .42 .17 .25 .004 .03
SERPINA5_P156_F .53 .08 .28 .14 .25 .002 .02
a Gene symbols are contained within the Feature ID before the first underscore.
b Mean b value (fractional methylation from 0 to 1).
c Features not present on the Illumina 1505 Cancer Methylation Panel I array.
and all 3 liver samples (fig. 3). Furthermore, analysis of
variation (ANOVA) showed that the methylation pattern
correlated much more strongly within a brain region
across individuals (728 of 1,505 CpG with correlation at
) than within an individual across brain regionsP ! .05
(151 loci of 1,505 CpG with correlation at ). TableP ! .05
3 shows the 20 most differentially methylated probes,
whereas table 4 contains a complete list of the 131 that
differed significantly. Of the 46 brain-region methylation
markers discovered in experiment 1, 32 were present on
the second array, and 26 of these were rediscovered as
significantly different in experiment 2. Among the genes
hypomethylated in cerebral cortex was SLC22A3 (MIM
604842), which encodes an extraneuronal monoamine
transporter that inactivates catecholamine neurotrans-
mitters and is thus a candidate gene for neuropsychiatric
disease.19 It has been shown to be imprinted in a tissue-
specific and temporally restricted fashion.20
In the third experiment, we again paired brain regions
from the same individuals, using seven from whom we
had matched cerebral cortex and pons regions, on the
same array as that in experiment 2. Again, there was strik-
ing separation of gene methylation, with clustering of
seven of seven cerebral cortex samples and seven of seven
pons (fig. 4). Similarly, ANOVA showed that the meth-
ylation pattern correlated much more strongly within
a brain region across individuals (292 of 1,505 CpG with
correlation at ) than within an individual acrossP ! .05
brain regions (116 of 1,505 CpG with correlation at P !
). Thus, methylation consistently distinguished brain.05
regions in a given individual. Table 5 shows the most
differentially methylated probes between cerebral cortex
and pons. Among the genes hypomethylated in cerebral
cortex in this experiment was insulin-like growth factor
1 (IGF1 [MIM 147440]), previously shown to have dis-
tinct developmental patterns of expression in differing
brain regions.21 Hypomethylated genes in pons included
FGF1 (MIM 131220) and FGFR2 (MIM 176943), fibroblast
growth-factor system genes that are part of a signaling
pathway that plays a role in brain development and
differentiation.22
We performed analyses of reliability and of potential
confounding, as well as validation experiments, to assess
the robustness of our findings. We tested the reproduci-
bility of methylation measurements of the arrays, exam-
ining seven samples at 1,505 CpG sites. Linear-regres-
sion analysis was performed, and correlation coefficients
ranged from 0.94 to 0.99. To control for any effects that
might be attributable to disease state, we assessed for dif-
ferences in DNA methylation between normal and dis-
ease-affected samples. We found no correlation, using all
1,505 CpG loci, comparing unaffected individuals (np
) with those with bipolar disorder ( ) and autism16 np 4
( ) in cerebral cortex (fig. 5A), cerebellum (fig. 5B),np 13
or pons (fig. 5C).
Finally, we sought to validate the observed methylation
data by an independent method, bisulfite pyrosequenc-
ing, which measures methylation variation at 190% pre-
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Figure 3. Hierarchical clustering of methylation data from cerebral cortex, cerebellum, and liver samples analyzed in experiment 2.
Methylation profiles of 1,505 CpG sites from 55 samples (26 cerebra, 26 cerebella, and 3 livers) from the same individuals were clustered
using uncentered correlation and pairwise average linkage. Columns represent samples; rows correspond to CpG sites. Clustering of 26
of 26 cerebella, 25 of 26 cerebra, and all 3 livers is shown by the dendrogram. A heat map showing relative methylation differences
(red indicates more methylated; blue indicates less methylated) from a handful of loci analyzed is represented below the clustering
dendrogram. The heat map shows genes with greatest difference between the groups (complete list in table 4).
cision.23 Bisulfite-pyrosequencing validation was per-
formed by bisulfite treatment of genomic DNA (Qiagen
Epitect kit), PCR amplification, and pyrosequencing of
CpG sites. We obtained sequences for all Illumina probes
and designed flanking primers (methylation-unbiased
nested PCR and sequencing primers) to the CpG site for
which a b value was reported by Illumina (available from
the authors on request). Pyrosequencing was performed
on a Biotage PSQ HS96 Pyrosequencer. Bisulfite conver-
sion controls and quantitative levels of methylation for
each CpG dinucleotide were evaluated with Pyro Q-CpG
software.
We chose genes for validation that showed a range of
variation between tissues on the arrays, including 12%,
24%, and 36% differences. Six genes in 2–20 samples were
analyzed for quantitative methylation by bisulfite pyro-
sequencing. All the loci tested showed substantial differ-
ences in DNA methylation across brain regions in the
same direction and magnitude as we had found using Il-
lumina arrays (fig. 6). For example, the Illumina data had
revealed hypermethylation of HDAC7A in cerebellum
compared with cerebrum by a magnitude of 0.33 in ex-
periment 1 and 0.36 in experiment 2; in pyrosequencing,
we also saw hypermethylation of cerebellum relative to
cerebrum by a magnitude of 0.46. Linear regression was
performed, comparing the percentage of methylation re-
ported by pyrosequencing and Illumina b values, and cor-
relation coefficients equaled 0.99 (EN2), 0.89 (HTR2A),
0.96 (GABRB3), 0.72 (MT1A), 0.74 (RASSF1), and 0.76
(HDAC7A).
To assess the reproducibility of our methylation results
in an independent set of individuals, we obtained snap-
frozen brain tissue (donated by The Stanley Medical Re-
search Institute’s brain collection, courtesy of Drs. Michael
B. Knable, E. Fuller Torrey, Maree J. Webster, and Robert
H. Yolken) and performed bisulfite pyrosequencing of six
genes (RASSF1, HDAC7A, HTR2A, GABRB3, EN2, and
MT1A) in 52, 46, 55, 33, 30, and 57 paired cerebral cortex
and cerebellum samples, respectively. All six of the loci
confirmed our initial brain-region methylation findings
in this independent set of individuals (fig. 7).
Finally, we examined the pattern of gene expression of
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Table 3. Loci Demonstrating Greatest Differential
Methylation ( ; ) between MatchedP ! .004 b 1 0.17
Cerebral Cortex and Cerebellum Samples from the Same
Individual
Feature IDa
Cerebellum
Meanb
Cerebral Cortex
Meanb Differenceb
SFTPA1_E340_R .18 .96 .78
RBP1_P426_R .98 .30 .68
HPN_P823_F .12 .79 .67
MAPK9_P1175_F .31 .94 .63
JAK3_P1075_R .15 .77 .63
BCR_P422_F .14 .76 .62
MYCL2_P19_F .83 .22 .61
ACVR1_P983_F .12 .71 .59
MAPK4_E273_R .13 .72 .59
IL1RN_P93_R .13 .67 .55
IL8_E118_R .08 .62 .54
SLC22A3_P528_F .90 .37 .53
PIK3R1_P307_F .18 .70 .52
FGF3_P171_R .56 .04 .52
PLA2G2A_P528_F .39 .90 .50
CD9_P585_R .11 .59 .48
SERPINE1_P519_F .07 .55 .48
TRIP6_P1090_F .10 .57 .47
LIMK1_P709_R .11 .58 .47
BLK_P14_F .10 .56 .46
a Gene symbols are contained within the Feature ID before the first
underscore.
b Mean b value (fractional methylation from 0 to 1).
Figure 4. Hierarchical clustering of methylation data from ce-
rebral cortex and pons samples analyzed in experiment 3. Meth-
ylation profiles of 1,505 CpG sites from 14 brain samples (7 cerebra
and 7 pons) from the same individual were clustered using un-
centered correlation and pairwise average linkage. Columns rep-
resent samples; rows correspond to CpG sites. Two major branches
are defined by our methylation data and correlate with brain re-
gion: one containing seven of seven cerebra and one containing
seven of seven pons. A heat map showing relative methylation
differences (red indicates more methylated; blue indicates less
methylated) from a handful of loci analyzed is represented below
the clustering dendrogram.
Table 4. Loci Demonstrating Significant
Differential Methylation ( ;P ! .004
) between Cerebellum and Cerebralb 1 0.17
Cortex from the Same Individual
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
five genes, RASSF1, HDAC7A, GABRB3, EN2, and HTR2A.
We chose these genes because they represent a diverse set
of cellular functions, including regulation of cell prolif-
eration, chromatin structure modification, development,
and neurotransmission, and they represent three genes
(RASSF1, HDAC7A, and GABRB3) in which the analyzed
methylation sites were within the promoter and two genes
(EN2 and HTR2A) in which the sites were 11 kb from the
promoter. Two of these genes, one in which the CpG locus
analyzed was within the promoter (HDAC7A) and one in
which it was distal to the promoter (EN2), were not in the
commercial Illumina GoldenGate Methylation Cancer
Panel I but were added to a custom array on the basis of
our identification of genes with altered expression in re-
sponse to TSA, a chromatin-modifying drug, or 5-aza-
deoxycytidine, a drug known to decrease DNA methyla-
tion.14 In all three cases in which the methylated sites were
within the promoter, the difference in expression was as
expected—that is, the more-methylated tissue showed the
lower mean expression, although, in one of these cases,
the results did not achieve statistical significance (table 6).
Interestingly, in both cases in which the methylated sites
lay outside the promoter, the more-methylated tissue also
showed the greater expression. Similar to our findings that
EN2 expression is decreased in brain tissue with less meth-
ylation, Gius et al.14 previously discovered that expression
of EN2 is down-regulated 1.7-fold in response to TSA, a
chromatin-modifying drug that normally results in in-
creased gene expression.
In summary, we have found a DNA methylation sig-
nature that distinguishes three human brain regions.
These brain methylation differences correlated much
more strongly within a brain region across individuals
than within an individual across brain regions. The result
is surprising, since the genes analyzed were not preselected
for known brain function. They came from a panel of
genes previously known to show altered DNA methylation
or a functional role in tumor development or progression.
Of course, these same genes are themselves implicated
generally in normal development and differentiation, and
80% of all genes are expressed in the normal brain.8 A
substantial body of evidence shows brain region–specific
differences in gene expression,9,10 and the region-specific
patterns in DNA methylation shown here may help to
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Table 5. Loci Demonstrating Significant Differential Methylation
( ; ) between Cerebral Cortex and Pons from the SameP ! .004 b 1 0.17
Individual
Feature IDa
Cerebral
Cortex Pons
Differenceb P
False-
Discovery
RateMeanb SD Meanb SD
HTR2A_E10_R .62 .06 .84 .04 .22 .002 .05
MATK_P190_R .35 .08 .55 .09 .20 .002 .05
WRN_P969_F .31 .05 .50 .10 .19 .002 .05
BCR_P346_F .20 .05 .38 .09 .19 .002 .05
IGF1_E394_F .42 .09 .60 .04 .18 .002 .05
DKFZP564O0823_P386_F .39 .04 .57 .07 .18 .002 .05
TNFSF10_E53_F .54 .13 .20 .05 .34 .004 .05
SERPINE1_P519_F .62 .13 .32 .05 .30 .004 .05
FGFR2_P460_R .52 .12 .23 .06 .30 .004 .05
AXIN1_P995_R .53 .16 .82 .06 .29 .004 .05
CD40_E58_R .48 .06 .20 .07 .28 .004 .05
SPARC_P195_F .39 .09 .13 .05 .26 .004 .05
PRKCDBP_P352_R .72 .07 .48 .07 .24 .004 .05
TJP2_P518_F .29 .11 .07 .03 .22 .004 .05
ZMYND10_P329_F .19 .08 .39 .11 .21 .004 .05
CASP10_P186_F .72 .06 .52 .06 .20 .004 .05
TNF_P158_F .65 .07 .45 .20 .20 .004 .05
CDK2_P330_R .20 .08 .01 .01 .20 .004 .05
FGF1_E5_F .52 .11 .32 .05 .20 .004 .05
CASP10_P334_F .71 .09 .52 .05 .19 .004 .05
MPO_P883_R .70 .05 .51 .08 .18 .004 .05
RAB32_P493_R .53 .08 .35 .06 .18 .004 .05
IL8_E118_R .60 .06 .42 .07 .18 .004 .05
STAT5A_E42_F .66 .06 .48 .04 .18 .004 .05
MMP9_P189_F .88 .05 .71 .04 .17 .004 .05
a Gene symbols are contained within the Feature ID before the first underscore.
b Mean b value (fractional methylation from 0 to 1).
explain these functional differences. Furthermore, because
methylation variation in tissues is acquired developmen-
tally, the differences in brain methylation may help to
determine or stabilize normal brain differentiation. This
idea is consistent with the fact that a failure to recognize
DNA methylation marks caused by absence of the MECP2
protein in Rett syndrome causes progressive loss of neu-
rodevelopmental milestones, as well as poorly regulated
gene expression in affected brain tissue.24
These data highlight several areas for further study. First,
the degree of complexity of the brain is greater than that
of any other organ. In addition to the gross brain-region
distinctions, such as cerebral cortex and cerebellum, the
cerebral cortex itself is broadly divided into four lobes and
is more finely divided into 47 Brodmann areas. Further-
more, in the classic studies by Mountcastle, the cortex is
functionally organized into countless vertical columns
∼300–600 mm wide.25 In addition, cellular complexity in-
volves both differing compositions of neurons and glia,
as well as potential differences among subtypes of those
classes, such as oligodendrocytes and astrocytes. This cel-
lular complexity may also be a major contributor to dif-
ferences among brain regions. Thus, it will be important
to analyze DNA methylation across a great many brain
subregions and cell types. However, such studies will likely
require whole genome–based approaches, to discover the
genes and potentially intergenic regions that epigeneti-
cally distinguish individual brain regions. Such technol-
ogies are emerging and should be generally available
within the next few years. A second issue for further study
is the degree to which brain epigenetic signatures might
be altered in disease. Although we found no evidence of
variation in bipolar disorder (also known as MAFD1 [MIM
125480]) or autism in these brain regions, our study was
not designed to detect such variation. Both our sample
size and our gene set were small and were not targeted to
functional candidates. A third issue is the developmental
role of methylation variation in the brain. Differential
methylation may affect an early event in brain develop-
ment, having an impact even in the absence of adult brain
expression of the relevant genes. Sorting this out will re-
quire animal models involving both genetics and epige-
netics. For example, one might knock out a brain region–
specific methylation mark to determine its functional
effect on the normal development of that region. A fourth
issue is the relationship of brain methylation to expres-
sion. Although, in three instances, increased methylation
in our samples correlated with gene silencing, in two oth-
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Figure 5. Hierarchical clustering of methylation data from cerebral cortex, cerebellum, and pons samples analyzed in experiments 2
and 3. Columns represent samples, rows correspond to CpG sites, and heat maps showing relative methylation differences (red indicates
more methylated; blue indicates less methylated) from a handful of loci analyzed are represented below the clustering dendrograms.
All clustering analyses were performed using uncentered correlation and pairwise average linkage. A, Methylation profiles of 1,505 CpG
sites from 33 cerebra samples (16 from normal individuals, 13 from individuals given diagnoses of autism, and 4 from individuals with
bipolar disorder) were clustered. Clustering does not reveal disease-specific branches. B, Methylation profiles of 1,505 CpG sites from
26 cerebella samples (13 from normal individuals and 13 from individuals given diagnoses of autism) were clustered. Clustering does
not reveal an autism-specific branch. C, Methylation profiles of 1,505 CpG sites from seven pons samples (three from normal individuals
and four from individuals with bipolar disorder) were clustered. Clustering does not reveal a bipolar-specific branch.
ers that were outside promoters, methylation sites likely
represent regulatory regions in which methylation is as-
sociated with gene expression. Similarly, Gius et al.14
found that half of genes showing altered expression after
demethylation become silenced rather than activated.
Finally, the identification of brain region–specific meth-
ylation differences shows that there are stable marks her-
itable during cell division that distinguish one brain re-
gion from another and are consistent in these differences
from one individual to another. These differences in meth-
Figure 6. Box plots of methylation data from bisulfite-pyrosequencing analysis. A, RASSF1. B, HDAC7A. C, HTR2A. D, GABRB3. E, EN2.
F, MT1A. Mean methylation levels across all Illumina experiments are denoted by blue lines. n is the number of samples analyzed by
pyrosequencing.
Figure 7. Box plots of methylation data from bisulfite-pyrosequencing analysis. A, RASSF1. B, HDAC7A. C, HTR2A. D, GABRB3. E, EN2.
F, MT1A. n is the number of samples analyzed by pyrosequencing.
1314 The American Journal of Human Genetics Volume 81 December 2007 www.ajhg.org
Table 6. Quantitative Real-Time PCR Results of Five Genes
Assayed in Paired Cerebellum and Cerebral Cortex Samples
from 15 Individuals
Measure RASSF1 HDAC7A GABRB3 EN2 HTR2A
Methylationa CM 1 CBL CBL 1 CM CBL 1 CM CBL 1 CM CM 1 CBL
Distanceb 200 200 440 6500 1400
Fold changec 2.0 1.5 1.4 100 40.4
P .011 .007 .210 !.001 !.001
Expressiond CBL 1 CM CM 1 CBL CM 1 CBL CBL 1 CM CM 1 CBL
NOTE.—CBL p cerebellum; CM p cerebral cortex.
a Methylation level from greatest to least, based on b value.
b Distance (in bp) to transcriptional start site from the locus showing
differential methylation across brain regions.
c Fold change p 2DDCT; DDCT p (CT cerebrum target geneCT phosphglycerate kinase 1)
(CT cerebellum target geneCT phosphglycerate kinase 1).
d Quantitative real-time PCR result. For each gene, brain-region ex-
pression is ranked from greatest to least.
ylation appear to be widespread at the gene level, perhaps
reflecting global regulation rather than discrete effects at
a small number of genes. Although these results are in a
relatively early stage, they do raise the intriguing possi-
bility that epigenetic signatures in part determine the
functional programs that have been traditionally associ-
ated with neuroanatomical distinctions.
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